1 |
Arnaout, M. A., Mahalingam, B., and Xiong, J. P. (2005) Integrin structure, allostery, and bidirectional signaling. Annu. Rev. Cell Dev. Biol. 21, 381−410
|
2 |
Bilsland, C. A., Diamond, M. S., and Springer, T. A. (1994) The leukocyte integrin p150,95 (CD11c/CD18) as a receptor for iC3b. Activation by a heterologous subunit and localization of a ligand recognition site to the I-domain. J. Immunol. 152, 4582−4589
|
3 |
Choi, J., Leyton, L., and Nham, S-U. (2005) Characterization of I-domain binding to Thy-1. Biochem. Biophy. Res. Commun. 331, 557−561
|
4 |
Dutch, D. G. and Mertz, E. T. (1970) Plasminogen purification from human plasma by affinity chromatography. Science 170, 1095−1096
DOI
|
5 |
Emsley, J., Knight, C. G., Farndale, R. W., Barnes, M. J., and Liddington, R. C. (2000) Structural basis of collagen recognition by integrin . Cell 101, 47−56
|
6 |
Nham, S-U. (1999) Characteristics of fibrinogen binding to the domain of CD11c, an subunit of p150,95. Biochem. Biophys. Res. Commun. 264, 630−634
|
7 |
Syrovets, T., Tippler, B., Rieks, M., and Simmet, T. (1997) Plasmin is a potent and specific chemoattractant for human peripheral monocytes acting via a cyclic guanosine monophosphatedependent pathway. Blood 89, 4574−4583
|
8 |
Ugarova, T. P. and Yakubenko, V. P. (2001) Recognition of fibrinogen by leukocyte integrins. Ann. NY Acad. Sci. 936, 368−385
|
9 |
Vorup-Jensen, T., Ostermeier, C., Shimaoka, M., Hommel, U., and Springer, T. A. (2003) Structure and allosteric regulation of the integrin I-domain. Proc. Natl. Acad. Sci. USA 100, 1873−1878
|
10 |
Xiong, J.-P., Li, R., Essafi, M., Stehle, T., and Arnaout, M. A. (2000) An isoleucine-based allosteric switch controls affinity and shape shifting in integrin CD11b A-domain. J. Biol. Chem. 275, 38762−38767
|
11 |
Herren, T., Swaisgood, C. M., and Plow, E. F. (2003) Regulation of plasminogen receptors. Front Biosci. 8, 1−8
DOI
|
12 |
Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., et al. (2004) UCSF Chimera-a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605−1612
|
13 |
Tarui, T., Miles, L. A., and Takada, Y. (2001) Specific interaction of angiostatin with integrin in endothelial cells. J. Biol. Chem. 276, 39562−39568
|
14 |
Miles, L. A., Ginsberg, M. H., White, J. G., and Plow, E. F. (1986) Plasminogen interacts with human platelets through two distinct mechanisms. J. Clin. Invest. 77, 2001−2009
|
15 |
Parkkinen, J. and Rauvala, H. (1991) Interactions of plasminogen and tissue plasminogen activator (t-PA) with amphoterin: enhancement of t-PA-catalyzed plasminogen activation by amphoterin. J. Biol. Chem. 266, 16730−16735
|
16 |
Humphries, M. J. (2000) Integrin structure. Biochem. Soc. Trans. 28, 311−339
|
17 |
McGuire, S. L. and Bajt, M. L. (1995) Distinct ligand binding sites in the I-domain of integrin that differentially affect a divalent cation-dependent conformation. J. Biol. Chem. 270, 25866−25871
|
18 |
Irigoyen, J. P., Munoz-Canoves, P., Koziczak, M., and Nagamine, Y. (1999) The plasminogen activator system: biology and regulation. Cell Mol. Life Sci. 56, 104−132
|
19 |
Valeryi, K. L., Novokhatny, V., Yakubenko, V. P., Skomorovska- Prokvolit, H. V., and Ugarova, T. P. (2004) Characterization of plasminogen as an adhesive ligand for integrins (Mac-1) and (VLA-5). Blood 104, 719−726
|
20 |
Zhang, L. and Plow, E. F. (1999) Amino acid sequences within the alpha subunit of integrin (Mac-1) critical for specific recognition of C3bi. Biochemistry 38, 8064−8071
|
21 |
Gonzales-Gronow, M., Gawdi, G., and Pizzo, S. V. (2002) Tissue factor is the receptor for plasminogen type 1 on 1-LN human prostate cancer cells. Blood 99, 4562−4567
|
22 |
Majumdar, M., Tarui, T., Shi, B., Akakura, N., Ruf, W., et al. (2004) Plasmin induced migration requires signaling through protease-activated receptor 1 and integrin . J. Biol. Chem. 279, 37528−37534
|
23 |
Pluskota, E., Soloviev, D. A., Bdeir, K., Cines, D. B., and Plow, E. F. (2004) Integrin orchestrates and accelerates plasminogen activation and fibrinolysis by neutrophils. J. Biol. Chem. 279, 18063−18072
|
24 |
Yakubenko, V. P., Solovjov, D. A., Zhang, L., Yee, V. C., Plow, E. F., et al. (2001) Identification of the binding site for fibrinogen recognition peptide 383−395 within the Idomain of integrin . J. Biol. Chem. 275, 13995−14003
|
25 |
Lee, J. O., Rieu, P. M., Arnaout, A., and Liddington, R. C. (1995) Crystal structure of the A domain from the Subunit of Integrin CR3 (CD11b/CD18). Cell 80, 631−638
|
26 |
Choi, J. and Nham, S.-U. (2002) Loops within the CD11c Idomain critical for specific recognition of fibrinogen. Biochem. Biophys. Res. Comm. 292, 756−760
|
27 |
Shortman, K. and Liu, Y. J. (2002) Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2, 151−161
DOI
ScienceOn
|
28 |
Plow, E. F., Herren, T., Redlitz, A., Miles, L. A., and Hoover- Plow, J. L. (1995) The cell biology of the plasminogen system. FASEB J. 9, 939−945
|
29 |
Diamond, M. S., Garcia-Aguilar, J., Bickford, J. K., Corbi, A. L., and Springer, T. A. (1993) The I-domain is a major recognition site on the leukocyte integrin Mac-1 (CD11b/CD18) for four distinct adhesion ligands. J. Cell Biol. 120, 1031−1043
|
30 |
Yakubenko, V. P., Lishko, V. K., Lam, S. C.-T., and Ugarova, T. P. (2002) A molecular basis for integrin ligand binding promiscuity. J. Biol. Chem. 277, 48635−48642
|
31 |
Gonzales-Gronow, M., Grenett, H. E., Weber, M. R., Gawdi, G., and Pizzo, S. V. (2001) Interaction of plasminogen with dipeptidyl peptidase IV initiates a signal transduction mechanism which regulates expression of matrix metalloproteinase 9 by prostate cancer cells. Biochem. J. 355, 397−407
|
32 |
Loike, J. D., Sodeik, B., Cao, L., Leucona, S., Weitz, J. I., et al. (1991) CD11c/CD18 on neutrophils recognizes a domain at the N terminus of the A alpha chain of fibrinogen. Proc. Natl. Acad. Sci. USA 88, 1044−1048
|